Caribou Biosciences, Inc. (CRBU)
1.665
-0.10
(-5.40%)
USD |
NASDAQ |
Aug 26, 12:16
Caribou Biosciences Profit Margin (Quarterly) : -1.62K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.62K% |
| March 31, 2026 | -1.05K% |
| December 31, 2025 | -672.1% |
| September 30, 2025 | -1.25K% |
| June 30, 2025 | -2.03K% |
| March 31, 2025 | -1.70K% |
| December 31, 2024 | -1.71K% |
| September 30, 2024 | -1.71K% |
| June 30, 2024 | -1.09K% |
| March 31, 2024 | -1.70K% |
| December 31, 2023 | -969.8% |
| September 30, 2023 | -42.27% |
| June 30, 2023 | -786.1% |
| Date | Value |
|---|---|
| March 31, 2023 | -800.8% |
| December 31, 2022 | -731.0% |
| September 30, 2022 | -806.8% |
| June 30, 2022 | -636.9% |
| March 31, 2022 | -716.5% |
| December 31, 2021 | -722.1% |
| September 30, 2021 | -527.4% |
| June 30, 2021 | -969.6% |
| March 31, 2021 | -829.7% |
| December 31, 2020 | -1.49K% |
| September 30, 2020 | -662.2% |
| June 30, 2020 | -22.08% |
| March 31, 2020 | -576.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -1.39K% |
| Vir Biotechnology, Inc. | 33.51% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -82.03% |
| Return on Assets | -58.27% |
| Return on Invested Capital | -67.81% |
| Gross Profit Margin (Quarterly) | 58.31% |
| Operating Margin (Quarterly) | -1.69K% |
| Return on Net Operating Assets | -402.7% |